🇺🇸 FDA
Patent

US 10202605

Methods of identifying and treating poor-prognosis cancers

granted A61KA61K31/00A61K31/337

Quick answer

US patent 10202605 (Methods of identifying and treating poor-prognosis cancers) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/00, A61K31/337, A61K31/704, A61K31/7105